Valsartan Lawsuit in USA: Blood Pressure Medication Risks

Patients in Texas with high blood pressure have had prescription-based access to Valsartan for several years. This medication was once a viable option for people managing the effects of hypertension and other heart-related conditions, but when the drug’s patent expired, other manufacturers produced versions of the drug. One of those manufacturers was Zhejiang Huahai Pharmaceutical Company (ZHP) in Linhai, China. After their product hit global markets, the United States Food and Drug Administration (FDA) and other global health agencies identified issues and released a recall.

In the summer of 2018, the FDA found the substance N-nitrosodimethylamine (NDMA) in the Chinese version of the drug. NDMA is a known carcinogen. This discovery was troubling enough, but a few weeks later, the news was worse: scientists found yet another cancer-causing substance, N-nitrosodiethylamine (NDEA). These toxic substances prompted the FDA to issue a voluntary recall of the drug.

As a result of the troubling information, Valsartan class action lawsuits in the United States are becoming more popular. Several states have initiated a Valsartan recall lawsuit, and Texas product liability lawyers have participated in this effort to hold the drug manufacturer accountable. In the wake of the Valsartan recall lawsuit, many patients are wondering what their next steps should be.

The FDA found the cancer-causing substances in specific batches of the drug. As a result of the Valsartan lawsuit in the USA, blood pressure medication risks are focused on a particular batch of the medication.

It’s important to note that if you suspect that you have cancer as a result of using Valsartan, some time may need to have passed since first using the drug for your claim to have weight. If, however, you started using or have used the drug beginning in 2014 and have used it for a minimum of six months to a year, you have substantial grounds for a claim (and, if you do not have cancer, you may be at serious risk for developing it).

Not all Valsartan is potentially toxic. Manufacturers in the United States have not produced tainted Valsartan. As of right now, the only medications of note are the products from the Chinese ZHP company. However, the Texas product liability lawyers at Carabin Shaw are prepared to speak with any patients who have developed cancer after being on a Valsartan regimen.

The people behind the Valsartan lawsuit in the USA know that blood pressure medication risks pose a serious threat to men and women in Texas. The discovery of potentially fatal substances has left many patients under a cloud of anxiety and stress. The challenge of dealing with a big drug company is daunting for many patients, who then feel as though pursuing redress may not be worth it.

The Texas attorneys at Carabin Shaw believe that patients who suffered from a defective, dangerous drug should receive compensation for their injuries and emotional distress. If you are one of these patients, we encourage you to call your physician to determine which version of Valsartan he or she prescribed. Then, give our office a call.

When you contact us, one of our Texas attorneys will schedule an appointment with you to discuss the details of your case. Your first visit with us is free of both charge and obligation on your part. If you decide to let us work on your behalf, we will protect your rights as a patient and ensure that you receive the compensation to which you are entitled.

Our Texas attorneys are ready to meet with you today. To schedule an appointment, call us toll-free at 800-862-1260.